Production des radionucléides
New experimental bremsstrahlung cross-section for light ion beams up to 60 MeV and comparison to theoretical models. Ralite F, Koumeir C, Guertin A, Haddad F, Mouchard Q, Servagent N, Metivier V. Radiation Physics and Chemistry. 2023. https://doi.org/10.1016/j.radphyschem.2022.110605
Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb. Wang Y, Sounalet T, Guertin A, Nigron E, Michel N, Haddad F. Applied Radiation and Isotopes. nov 2023;201:110996. https://doi.org/10.1016/j.apradiso.2023.110996
Research on Emerging Medical radionuclides from the X-sections (REMIX): The Accelerator-based Production of 47Sc, 149Tb, 152Tb, 155Tb and 161Tb. Pupillo G et al. J. Phys.: Conf. Ser. 2586 012118. https://doi.org/10.1088/1742-6596/2586/1/012118
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V. Mou L et al. Pharmaceuticals 2024, 17(1), 26. https://doi.org/10.3390/ph17010026
47Sc production with proton beams on isotopically enriched 48Ti and 49Ti targets, L De Dominicis et al 2023 J. Phys.: Conf. Ser. 2586 012128. http://dx.doi.org/10.1088/1742-6596/2586/1/012128
Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb, Wang Y, Sounalet T, Guertin A, Nigron E, Michel N, Haddad F, Applied Radiation and Isotopes. nov 2023;201:110996. https://doi.org/10.1016/j.apradiso.2023.110996
Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction ?, Nigron E, Guertin A, Haddad F, Granger L, Rayer M, Rintaud A, Applied Radiation and Isotopes. juill 2023;110927. https://doi.org/10.1016/j.apradiso.2023.110927
Discussions on liquid bismuth target use as an alternative for astatine-211 production, Bigourdan T, Cadiou A, Guertin A, Haddad F., Schumann D, Stodel C, Gott M, éditeurs. EPJ Web Conf. 2023;285:09002. https://doi.org/10.1051/epjconf/202328509002
Discussions on liquid bismuth target use as an alternative for astatine-211 production, Bigoudan T, Cadiou A, Guertin A, Haddad F., 30th Conference of the International Nuclear Target Development Society (INTDS2022). 22 juin 2023; EPJ Web Conf. Volume 285, 2023.